Article Versions Notes

Kostik M, Kalashnikova E, Rinat R, Isupova E, Gaidar E, Soloviev AA, Masalova V, Snegireva L, Kornishina T, Abramova N, et al. Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study. Biomedicines. 2023; 11(5):1503. https://doi.org/10.3390/biomedicines11051503

Kostik, Mikhail, Elvira Kalashnikova, Raupov Rinat, Eugenia Isupova, Ekaterina Gaidar, Anton A. Soloviev, Vera Masalova, Ludmila Snegireva, Tatyana Kornishina, Natalia Abramova, and et al. 2023. "Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study" Biomedicines 11, no. 5: 1503. https://doi.org/10.3390/biomedicines11051503

Kostik, M., Kalashnikova, E., Rinat, R., Isupova, E., Gaidar, E., Soloviev, A. A., Masalova, V., Snegireva, L., Kornishina, T., Abramova, N., Suspitsin, E., Sorokina, L., Kaneva, M., Dubko, M. F., Lubimova, N., Kuchuinskaya, E., Kalashnikova, O., & Chasnyk, V. (2023). Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study. Biomedicines, 11(5), 1503. https://doi.org/10.3390/biomedicines11051503